Roop P

Faculty of Engineering, University of Auckland, Auckland, 1023, New Zealand. Electronic address: p.roop@auckland.ac.nz.

4 papers

LSD microdosing in major depressive disorder: results from an open-label trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +12

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Daldegan-Bueno D, Donegan CJ, Forsyth A +16

LSD increases sleep duration the night after microdosing.

Allen N, Jeremiah A, Murphy R +8

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

Donegan CJ, Daldegan-Bueno D, Sumner R +15